The Discounted Cash Flow (DCF) valuation of Chordate Medical Holding publ AB (CMH.ST) is (1,580.49) SEK. With the latest stock price at 13.10 SEK, the upside of Chordate Medical Holding publ AB based on DCF is -12164.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 5.2% - 7.2% | 6.2% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (13,693.39) - (858.35) | (1,580.49) |
Upside | -104629.7% - -6652.3% | -12164.8% |